Hunan Jingfeng Pharmaceutical Co

Hunan Jingfeng Pharmaceutical Co Operating Cash Flow

The Operating Cash Flow of Hunan Jingfeng Pharmaceutical Co (000908.SZ) as of Oct 27, 2026 is 59.32 M CNY. In the previous year, Operating Cash Flow was -5.55 M CNY — a change of -1,168.67% (higher).

Operating Cash Flow

59.32 MCNY

YoY

-1,168.67%

Last updated:

Operating Cash Flow of Hunan Jingfeng Pharmaceutical Co is 2025 59.32 M CNY. Operating Cash Flow of Hunan Jingfeng Pharmaceutical Co was 2024 -5.55 M CNY. It decreases by -1,168.67% higher compared to the previous year.

The Hunan Jingfeng Pharmaceutical Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
350.94 M CNY
Jan 1, 2019
36.17 M CNY
Jan 1, 2020
-271.68 M CNY
Jan 1, 2021
123.83 M CNY
Jan 1, 2022
123.27 M CNY
Jan 1, 2023
35.06 M CNY
Jan 1, 2024
-5.55 M CNY
Jan 1, 2025
59.32 M CNY
The Hunan Jingfeng Pharmaceutical Co Operating Cash Flow history
YEAROperating Cash FlowYoY
59.32 MCNY-1,168.67%
-5.55 MCNY-115.83%
35.06 MCNY-71.55%
123.27 MCNY-0.46%
123.83 MCNY-145.58%
-271.68 MCNY-851.12%
36.17 MCNY-89.69%
350.94 MCNY+131.41%
151.65 MCNY+1,130.47%
12.32 MCNY-86.66%
92.37 MCNY-55.15%
205.93 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hunan Jingfeng Pharmaceutical Co Stock analysis

What does Hunan Jingfeng Pharmaceutical Co do? Hunan Jingfeng Pharmaceutical Co., Ltd. generates revenue through the research, development, manufacture, and sale of chemical and biological drugs. Its main product categories include cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs, and anti-infective drugs. The company distributes these products domestically and also engages in commodity import and export trading, business management and consulting, and medical technology consulting services. Sales are primarily directed at the domestic market with no mention of international distribution channels. The firm's revenue streams are derived from pharmaceutical sales, particularly in cardiovascular, oncology, and infectious disease treatments, alongside ancillary services such as medical technology consulting. The domestic market remains the sole focus for product distribution, with no indication of export-oriented sales. The company's operations are centered on drug manufacturing and related consulting services, targeting healthcare providers and domestic consumers through established distribution networks. Hunan Jingfeng Pharmaceutical's business model emphasizes product diversity across multiple therapeutic areas, including cardiovascular, oncology, and infectious diseases. The company's revenue is driven by both direct pharmaceutical sales and ancillary consulting services, with all activities confined to the domestic market. The absence of international operations or export-focused strategies is consistent with the business description provided. Hunan Jingfeng Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hunan Jingfeng Pharmaceutical Co stock

Operating Cash Flow of Hunan Jingfeng Pharmaceutical Co is 59.32 M CNY in 2025.

Operating Cash Flow of Hunan Jingfeng Pharmaceutical Co changed from -5.55 M CNY to 59.32 M CNY, representing a -1,168.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Hunan Jingfeng Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Hunan Jingfeng Pharmaceutical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Hunan Jingfeng Pharmaceutical Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Hunan Jingfeng Pharmaceutical Co